>like to hammer small biotechs after a nice run....your time is coming soon IMO.<
I'd welcome some ill-informed retail shorts. The only problem is that they tend to clutter the board with uninformative messages, frequently written in all caps.
Suggest you do a little due dilligence and see what kind of events you are getting in front of. Although the truly pivotal event for YMI is the tesmilifene PIII results, coming perhaps as early as June, there's a bunch of stuff to look forward to in the rest of Q1 and Q2.